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Abstract
Background: Admixture between early modern humans and Neandertals approximately 50,000–60,000 years ago
has resulted in 1.5–4% Neandertal ancestry in the genomes of present-day non-Africans. Evidence is accumulating
that some of these archaic alleles are advantageous for modern humans, while others are deleterious; however, the
major mechanism by which these archaic alleles act has not been fully explored.
Results: Here we assess the contributions of introgressed non-synonymous and regulatory variants to modern
human protein and gene expression variation. We show that gene expression changes are more often associated
with Neandertal ancestry than expected, and that the introgressed non-synonymous variants tend to have less
predicted functional effect on modern human proteins than mutations that arose on the human lineage.
Conversely, introgressed alleles contribute proportionally more to expression variation than non-introgressed alleles.
Conclusions: Our results suggest that the major influence of Neandertal introgressed alleles is through their effects
on gene regulation.
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Background
Some archaic alleles have been shown to confer an adap-
tive advantage for modern humans, and some of the most
striking candidates for adaptive introgression from Nean-
dertals are associated with traits related to environmental
adaptation, including immunity and high altitude and skin
and hair physiology in non-Africans [1–5]. However,
recent studies have explored the effects of selection on
archaic variants and have suggested that the depletion of
archaic ancestry around functional elements in the ge-
nomes of present-day people reflects widespread purifying
selection against archaic variants [5–7]. Selected variants
can exert their effect by modifying gene expression or by
changing the amino acid sequence [8–12]. Although both
mechanisms have been described for introgressed alleles,
and it has been suggested that regulatory changes are
likely to have a larger impact [8], the relative contribution
of each mechanism remains unknown.
Neandertal alleles that introgressed into modern humans
are likely to be those that were at an appreciable frequency
in the Neandertal population and are therefore likely to be
older than their generally low frequency in modern humans
suggests. To determine whether they have disproportional
functional impact compared to non-archaic variants of
matched frequency, we identify introgressed Neandertal
alleles in present day people that affect either protein cod-
ing potential or gene regulation and compare their effects
on molecular phenotypes to non-introgressed alleles of a
similar frequency. We are able to show that some of the
introgressed alleles that modify the molecular phenotype
are responsible for phenotypic variation in modern
humans. We also study changes in frequency of these
alleles to understand the selective pressures under which
they have evolved in recent modern human history.
Results
We defined putatively introgressed alleles as those that
differ between the Altai Neandertal and all Yoruba individ-
uals in the 1000 Genomes [13] (“Methods”) and that
overlap with the previously published Neandertal introgres-
sion map for modern humans [5] (“Methods”). Although it
is possible that a subset of sites are mis-labeled due to error,
incomplete lineage sorting, and the divergence between
introgressing and sequenced Neandertal genomes [14], this
approach enriches for alleles of Neandertal origin. We then
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annotated introgressed alleles that modify amino acid
sequences [15] and tested alleles within 50 kb of genes for
their association with gene expression in multiple human
tissues [16].
Impact of introgressed alleles on protein sequences
We detected a total of 930 alleles that result in non-
synonymous changes in present-day Eurasians (Europeans
701, East Asians 740, South Asians 841; “Methods”) and
compared the predicted effect of these changes using SIFT
and PolyPhen2 [17, 18] to the effects of a set of frequency-
matched, non-synonymous non-archaic alleles. SIFT and
PolyPhen2 provide two approaches to predict the func-
tional impact of amino acid substitutions based on their
proximity to functional domains, the physico-chemical
properties of the substitution, and evolutionary or protein
family conservation. We found that non-synonymous ar-
chaic alleles are predicted to have less effect (as measured
by the deleteriousness scores) than non-synonymous non-
archaic alleles (all P < 0.001; Fig. 1; “Methods”).
Impact of introgressed alleles on gene expression
To identify changes in gene expression that are potentially
mediated by introgressed alleles we used genotype and ex-
pression data for 48 tissues and 450 individuals (Additional
file 1: Table S1) provided by the GTEx consortium [16].
To identify loci that are potentially of archaic origin
we cluster alleles in high linkage disequilibrium (r2 > 0.8)
and then select an archaic-like tag allele for each of the
identified archaic loci (between 6118 and 9887 loci per
tissue; “Methods”; Additional file 1: Table S1). Similarly,
we identify non-archaic loci as those where none of the
alleles in linkage disequilibrium (LD) are of archaic origin
and select for each of these non-archaic loci a random tag
allele (between 919,090 and 1,640,104 loci per tissue). We
then identified between 4322 and 6008 expressed genes
within 50 kb of archaic loci and between 16,857 and
17,044 genes within 50 kb of non-archaic loci that are
potentially regulated by the archaic or non-archaic vari-
ants, respectively. For each tissue we computed genotype-
expression association (GEA) by correlating the genotypes
of the tag alleles with the expression of nearby gene/s
(“Methods”). Neandertal introgression results in longer
haplotypes—or at least haplotypes of a length consistent
with the introgression time—that are therefore more likely
to contain more alleles in LD (lengths of archaic and non-
archaic loci shown in Additional file 2: Figure S1). Picking
the best association may therefore be biased as there are
more potentially associated alleles to choose from in
archaic loci than in non-archaic loci. To avoid artificially
inflating associations for archaic loci we pick a random
allele to represent both archaic and non-archaic loci.
We identified loci in each tissue where an archaic allele
was significantly associated with an expression change
(false discovery rate (FDR) <0.05; “Methods”, Additional
file 1: Table S1). The number of significant archaic loci
(between 1 and 211) was highly correlated with the

















































Fig. 1 Functional impact of Neandertal non-synonymous alleles. Left: Average PolyPhen2 scores for archaic non-synonymous alleles in East Asians,
South Asians, and Europeans (red squares). These averages are compared to averaged Polyphen2 scores for 1000 frequency matched sets of non-
archaic non-synonymous alleles (yellow, orange, and brown violin plots). Polyphen2 scores range from 0–1 with higher scores associated with in-
creased deleteriousness. Right: Average SIFT scores for archaic non-synonymous alleles in East Asians, South Asians, and Europeans (red squares).
These averages are compared to averaged SIFT scores for 1000 frequency matched sets of non-archaic non-synonymous alleles (yellow, orange,
and brown violin plots). SIFT scores range from 0–1 with lower scores associated with increased deleteriousness
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indicating that our power to detect significant GEAs is
dependent on the number of individuals for which we
have data in a given tissue. This difference in power and
the variation of expression constraint between tissues [19,
20] made it difficult for us to directly compare results
between tissues. However, we observed a significant excess
of low P values among the top 5% of genes showing
differential expression that is related to Neandertal ances-
try, and therefore defined the top 5% of genes associated
with archaic loci to be significant GEAs for each tissue
(Additional file 2: Figure S2). We found that most GEAs
are detected in only one tissue (27% of GEAs) or are
shared between a small number of tissues (79% of signifi-
cant GEAs are shared between four or fewer tissues;
“Methods”). We caution that these results are sensitive to
differences in expression variation between tissues.
To determine whether introgressed alleles contribute
significantly to expression variation, we compared GEAs of
our archaic tag alleles to GEAs of a set of frequency-
matched non-introgressed tag alleles. Selecting frequency-
matched archaic and non-archaic alleles ensures that we
have similar power to detect expression differences. For
each tissue we computed the number of archaic loci with a
significant GEA (top 5% P values). When pooling all
tissues, we found that a significantly higher number of
archaic loci were associated with changed gene expression
compared to non-archaic loci (P < 0.001; “Methods”; Fig. 2).
When testing tissues individually, 23 of 48 tissues had sig-
nificantly more archaic loci associated with expression
changes than non-archaic loci (FDR < 0.05; “Methods”;
Additional file 1: Table S2).
Interestingly, there was no enrichment for differential
expression associated with archaic loci at lower frequencies
(archaic allele frequency <5%) when all tissues were com-
bined (P < 0.28; Fig. 2; “Methods”), and in only 10 of the 48
tissues individually (FDR <0.05; “Methods”; Additional file
1: Table S2), suggesting that the signal is mainly driven by
higher-frequency introgressed alleles. Indeed, archaic alleles
with a frequency ≥5% are enriched near genes that are
differentially expressed in the pooled tissue set (P < 0.001),
and also near genes that are differentially expressed in
many individual tissues (26/48 tissues with FDR <0.05).
Frequency changes in introgressed alleles
In order to study recent changes in the frequencies of intro-
gressed alleles in modern humans, we used selection scores
from a catalog of sites for which allele frequency data in a
set of modern humans ranging from around 8000 years to
the present day are available [21]. We extracted selection
scores from this set for 80 archaic non-synonymous alleles
in Europeans, 79 in South Asians, and 76 in East Asians.
Three of these non-synonymous archaic alleles are shared
between all populations and all three have significantly
decreased in frequency since 8000 years ago, which is
surprising given that there was an overall tendency for the
remaining set of 77 non-synonymous archaic alleles to in-
crease in frequency (51/77 show a non-significant increase,
Fisher’s exact test P = 0.04). When comparing archaic non-
synonymous alleles to frequency-matched, non-archaic
non-synonymous alleles we found that a similar proportion
of the non-archaic alleles show a significant frequency shift



































Fig. 2 Enrichment of significant GEA archaic loci compared to non-archaic loci across all tissues. Each violin plot shows the distribution of the
ratio between the number of significant archaic GEAs and 1000 samples of significant non-archaic GEAs for all archaic loci (blue), the subset of
archaic loci with a Neandertal allele frequency <5% (dark blue), and the subset of archaic loci with a Neandertal allele frequency ≥5% (light blue)
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P = 0.15; FDR = 0.16 for all populations; “Methods”). How-
ever, a higher fraction of non-archaic alleles increased sig-
nificantly in frequency in all populations than was the case
for the archaic alleles (Europe P = 0.04, East Asia P = 0.03,
South Asia P = 0.05; FDR = 0.05 for all populations;
“Methods”). We also compared the frequency changes in
non-synonymous archaic alleles to changes in synonymous
archaic alleles. We identified 743 synonymous archaic al-
leles in East Asians, 886 in South Asians, and 766 in Euro-
peans and extracted selection scores from Mathieson et al.
[21] for 37, 44, and 44, respectively. Since there was no dif-
ference in the distributions of archaic allele frequencies for
synonymous and non-synonymous sites (P = 0.63 Mann-
Whitney-U test; “Methods”) we compared the proportion
of significant selection scores for archaic synonymous and
non-synonymous alleles directly. We found five synonym-
ous archaic alleles in all three populations that showed sig-
nificant frequency changes; two of them increased in
frequency over time, while three decreased. The fraction of
alleles that increased significantly is not statistically signifi-
cantly higher than the fraction of archaic non-synonymous
alleles (Europe and South Asia P = 0.13, East Asia P = 0.05,
FDR = 0.13 for all three populations; “Methods”). Our re-
sults suggest that archaic non-synonymous variants de-
creased in frequency more often than expected compared
to non-archaic non-synonymous variants and show similar
frequency changes to those seen among archaic synonym-
ous variants. This is consistent with similar or slightly more
negative selection on archaic amino acid-changing variants
compared to non-archaic amino acid-changing variants.
However, we note that these results are based on very few
alleles and that additional data would be useful to confirm
these observations.
We show above that high frequency archaic alleles
(≥5%; Additional file 1: Table S2) seem to contribute
more to differences in gene expression, suggesting that
introgressed variants in regulatory regions may have in-
creased in frequency in non-Africans. To determine the
extent to which archaic alleles that modify expression
have changed in frequency in recent human history, we
first assigned to each significantly associated archaic
locus (GEA) the most significant selection score for an
archaic allele (lowest P value) within the locus. For com-
parison, we selected as many frequency-matched non-
archaic loci that are equally strongly associated with dif-
ferential expression and assign to these the most signifi-
cant selection score for the locus (“Methods”). We find
that archaic loci associated with differential expression
in a pooled set of all tissues show significant frequency
changes more often than frequency-matched non-
archaic loci (P < 0.001; “Methods”; Additional file 1:
Table S3). Similarly, when we compare archaic loci asso-
ciated with differential expression to frequency-matched
archaic loci that are not associated with differential
expression, we find that expression-changing archaic loci
show more significant frequency changes than archaic
loci that do not change expression (P < 0.001; Additional
file 1: Table S3; “Methods”). We show that archaic alleles
associated with differential expression significantly
change their frequency more often than expected, and
that 54% of archaic alleles associated with differential
expression decreased significantly in frequency, which
was less than observed in the matched sets of archaic
alleles with no expression differences (57–67%, P < 0.001;
“Methods”). In contrast, matched non-archaic alleles
associated with expression changes showed an average
53% increase in allele frequencies (ranging between
48 and 59%, P < 0.001; Fig. 3; Additional file 2: Figure
S3; “Methods”). We note that the archaic alleles asso-
ciated with expression changes were ascertained in
pre-dominantly Europeans from the GTEx panel and
therefore they may not be representative of the regu-
latory effect in other non-African populations.
Overall, non-synonymous archaic alleles and archaic
alleles associated with expression changes have decreased
in frequency over the past ~8500 years. However, we identi-
fied four loci where the archaic alleles associated with dif-
ferential expression show large increases in frequency over
time (Additional file 1: Table S4; “Methods”). Among these
are introgressed alleles modifying expression of the OAS1/
OAS2/OAS3 genes, which are involved in innate immunity.
Elevated introgression has already been reported [22] for
these genes and we find that the expression-changing alleles
exhibit the most extreme change in frequency (corrected P
value = 1.14 × 10−8, genome-wide rank 314 across all SNPs)
with archaic alleles reaching frequencies of 28–44% in
present-day Europeans and 16–35% in present-day Asians
(Additional file 1: Table S4; Additional file 2: Figure S4).
Interestingly, we observe tissue-specific differences in the
effects of the archaic alleles on gene expression (Fig. 4). For
example, the OAS1, OAS2, and OAS3 genes are in the top
5% GEA loci in four, two, and eight tissues, respectively
(Additional file 1: Table S4). Archaic alleles in OAS1 are
associated with higher expression in subcutaneous adipose
tissue and sun-exposed skin, while higher expression in
thyroid and pancreas and vagina is associated with archaic
alleles in OAS2 and OAS3, respectively. In contrast, individ-
uals carrying archaic alleles show down-regulation of OAS1
and OAS3 in esophagus mucosa and spleen, and individuals
carrying archaic alleles show down-regulation of OAS2 in
fibroblasts and OAS3 in fibroblasts as well as three brain re-
gions (hippocampus, putamen, and caudate nucleus; Fig. 4).
The tissue-specific effects of these archaic alleles suggest
that they may be functionally relevant.
Phenotype associations
To determine whether archaic alleles influence particular
phenotypes in present-day humans, we identified from
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among the top 1% of archaic GEAs 14 loci (P value <10-8)
where an archaic allele in the locus matches an allele
previously reported to be significantly associated in one or
more genome-wide association studies, and a further six
archaic alleles that match the most significant GWAS as-
sociation in one or more studies (1 × 10−8 < P value
< 1 × 10−5; Additional file 1: Table S5). Similarly, we iden-
tify six non-synonymous archaic alleles with significant
GWAS associations (P value <10−8) and three that match
the most significant GWAS association in one or more
studies (1 × 10−8 < P value < 1 × 10−5). It is difficult to con-
struct a meaningful enrichment test that accounts for con-
founding factors present in this collection of GWAS
studies, but we note that for both non-synonymous and
regulatory changes there are a number of categories asso-
ciated with metabolic pathways and with immunity, as
well as a number of neurological associations. Interest-
ingly, we are now able to elucidate the molecular impact
of three of the variants reported in Sankararaman et al.
[5]. The introgressed haplotype at ZNF365 (rs7076156,
hg19, chr10:64415184) carries a non-synonymous allele
associated with risk of Crohn’s disease with frequencies up
to 32% in Europeans [23]; Additional file 1: Table S6). In
addition, an archaic allele on chromosome 11 (rs1834481,
hg19, chr11:112023827) is associated with reduced ex-
pression of IL18 in multiple tissues, including the pan-
creas, and IL18 levels/markers of inflammatory
response in two GWAS studies [24, 25] and present in
Europeans at frequencies up to 24%. Another regulatory
archaic variant, rs12531711 (hg19, chr7:128617466),
modifies the expression of TNPO3 in brain and is associ-
ated with multiple auto-immune phenotypes [26–35]
(Additional file 1: Table S6).
Further, we find a GEA locus which includes rs17612333
(hg19, chr4:169330384) for which the archaic allele is asso-
ciated with reduced expression of DDX60L in subcutaneous
adipose tissue and an increased body mass index (BMI) in
Native Americans [36]. The archaic allele is present at
frequencies between 13 and 21% in European populations
and shows similar frequencies in Asians (8–15%; Additional
file 1: Table S6; Additional file 2: Figure S4). A second ar-
chaic GEA locus that is associated with changed expression
of COL13A1 includes rs17497526 (hg19, chr10:71580120),
an allele associated with Parkinson’s disease risk in North
Americans [37]. The risk allele is likely of archaic origin,
and individuals carrying the archaic allele in the GTEx
dataset show significantly lower expression of COL13A1 in
the cerebellum compared to individuals without the intro-
gressed archaic allele. The archaic allele is more prevalent
in European populations (7–15%) than in Asians (2–11%),
with the frequency in East Asian populations substantially
lower (2–5%; Additional file 1: Table S6; Additional file 2:
Figure S4). It is intriguing that some studies that have
suggested a lower prevalence of Parkinson’s disease in Asia
[38], opening the question of whether the archaic introgres-






































Fig. 3 Direction of change for alleles showing significant frequency changes in recent modern human history. Left: The percentage of archaic alleles
showing association with differential expression in at least one tissue that increase in frequency, and comparison to two sets of frequency matched
alleles: (i) archaic alleles not associated with differential expression; and (ii) non-archaic alleles that are associated with differential expression. Right:
The percentage of non-synonymous archaic alleles that increase in frequency compared to (i) synonymous archaic alleles and (ii) frequency-matched,
non-synonymous non-archaic alleles
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Discussion
Recent studies have shown that Neandertal alleles are de-
pleted in more constrained, functional regions of the gen-
ome and that, on average, selection has acted to remove
introgressed Neandertal alleles from the modern human
population [5, 7, 39]. Despite these general patterns, a
number of instances of adaptive introgression have been
described, generally affecting systems that influence im-
mune and metabolic phenotypes [1, 5, 10, 22, 40, 41]. The
mechanisms by which these adaptive alleles act have not
been widely explored. We show here that Neandertal
alleles contributing to variation in protein sequences and
expression have, in general, decreased in frequency during
recent modern human history. This is particularly the case
near protein coding genes, and is consistent with negative
selection on Neandertal DNA in modern humans [5, 6, 7,
39]. However, we cannot exclude the possibility that some
of the introgressed variants also experienced negative se-
lection in Neandertals prior to admixture. The difference
in deleteriousness between frequency matched archaic
and non-archaic alleles in modern humans may therefore
reflect a mixture of these two effects.
The surviving Neandertal DNA seems to have contrib-
uted significantly to variation in gene expression in mod-
ern humans compared to other non-introgressed variants.
Although the enrichment for differential expression linked
to archaic ancestry is only between ~5 and 10% for all tis-
sues, the fact that there are thousands of archaic alleles
across the genome means that the expression of several














































































Fig. 4 Global frequency distribution of archaic alleles at the OAS gene cluster and differential expression for OAS3. The frequency of the archaic locus
(orange) spanning the OAS gene cluster in present-day human populations from the 1000 Genomes phase III (light blue) and Simons Genome Diversity
Project (dark blue) datasets are shown in the upper panel. The sizes of the pie charts are proportional to the number of individuals in each population.
The lower panel shows the genotype-dependence of expression (log-transformed read counts) of OAS3 in pancreas (left) and fibroblasts (right). The
expression distributions for both homozygote and the heterozygote states are shown as box plots and expression in each individual is plotted as a
black square. The Spearman correlation coefficient and the corresponding P value for both tissues are shown above each graph. The introgressed
Neandertal allele is the “A” (chr12:113366899)
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higher frequency archaic variants contribute significantly
more to gene expression changes than lower frequency
archaic variants, suggesting that at least some of the ar-
chaic alleles that modify gene expression may have been
driven to higher frequencies by positive selection, and
supporting the idea that changes in gene expression are
likely to have important adaptive effects in humans [42].
Conclusions
We provide evidence that changes in both protein se-
quence and in expression introduced by Neandertal
DNA have phenotypic consequences for present-day
people. However, our results indicate that introgressed ar-
chaic DNA is likely to exert a larger effect through
changes in gene regulation than through modifications to
protein sequences.
Methods
Genotype data and assignment of putative introgressed
variants
We used genotype data for 450 individuals for whom
expression data are also available (GTEx [43] version 6;
Additional file 1: Table S1). Of a total of 10,531,619
SNPs in GTEx, we used 7,400,760 that are located
50 kb up- and downstream of protein-coding genes
(ENSEMBL: GRCh37) and showed variation between in-
dividuals. These SNPs were then assigned to each of the
protein-coding genes that were located within 50 kb of
the SNP.
Next, we clustered SNPs into two sets. The first set con-
sisted of 105,046 putative introgressed Neandertal-like SNPs
(aSNPs), which we defined as having (i) one fixed allele in
Yoruba individuals of the 1000 Genomes project (phase III)
[13], (ii) a different allele in a heterozygous or homozygous
state in the genome of the Altai Neandertal [14] which
segregates in out-of-African GTEx individuals, and (iii)
overlap with confidently inferred regions of Neandertal-
introgression in modern humans. These introgressed re-
gions are required to have a Neandertal posterior probabil-
ity greater than 0.9 and a length of at least 0.02 cM [5]. The
second set contained 7,282,603 SNPs that are not likely to
be of archaic origin, i.e., SNPs where the Neandertal-shared
allele is also present in Yoruba individuals. We call these
“non-introgressed alleles”. The remaining 13,111 SNPs that
do not fall in either set were excluded from any further ana-
lyses (Additional file 1: Table S1).
Expression data
We used expression data for multiple individuals from
48 tissues for which at least 50 individuals with available
genotype data were provided by GTEx (Additional file 1:
Table S1). Five tissues with 5–26 individuals were
excluded (Additional file 1: Table S1). All protein-coding
genes for which at least two of the individuals for the
given tissue had a read count greater than zero were
defined as expressed in this tissue and were used in the
following analyses (Additional file 1: Table S1). We use
this low cut-off to accommodate the low frequency
(~2%) of typical Neandertal alleles. Read counts for all
expressed genes in a tissue were then normalized be-
tween individuals using the R package DESeq2 [44].
Computing genotype-dependent expression (GEA)
For all SNPs for which we had at least two genotypes
with a minimum of two individuals each, we computed
Spearman’s correlation between the genotype, encoded
as 1 (homozygous reference allele), 2 (heterozygous),
and 3 (homozygous alternative allele), and the normal-
ized expression of the nearby gene(s).
Clustering of alleles in high LD
We clustered sets of alleles in high LD. We used PLINK
[45] and combined sets of alleles with an r2 ≥ 0.8 into one
locus (PLINK parameters –ld-window-r2 0.8 –ld-window
99999). For each set of linked alleles we assign one of two
possible classes: Neandertal-like or non-archaic. A set of
linked alleles was defined to be Neandertal-like if at least
one allele is Neandertal-like (“Neandertal-like locus”). Sets
of linked alleles without Neandertal-like alleles were
defined to be non-archaic (“non-archaic locus”). It is pos-
sible for both sets that loci contain a single SNP if no
other variant in high LD could be identified. For each set
of linked alleles we chose a representative allele using two
algorithms to select this allele: in Neandertal-like sets the
representative allele was either (i) the Neandertal-like al-
lele within the set with the most significant genotype-
expression correlation or (ii) a random Neandertal-like
allele. In the non-archaic the representative allele was
either (i) the allele within the cluster with the most signifi-
cant genotype-expression correlation or (ii) a random
allele. Representative alleles defined according to the sec-
ond criterion were used for statistical analysis comparing
archaic and non-archaic loci in order to avoid differences
in power. The sets defined by the first criterion were used
for the GWAS comparison and for the comparison of top
GEA loci between tissues (see following section "Contri-
bution of archaic loci to differential expression" for
details).
In total we obtained data for 1,652,478 to 3,002,785
gene loci per tissue (Additional file 1: Table S1).
Contribution of archaic loci to differential expression
To quantify the extent of differential expression associated
with archaic loci compared to non-archaic loci we selected
in each tissue the GEAs for all archaic loci. We computed
the empirical tissue-specific 5% quantiles on the corre-
sponding tissue’s P value distributions. For each tissue we
randomly selected the identical number of frequency-
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matched non-archaic loci, i.e., non-archaic loci with the
same frequency distribution of their tag-alleles as the
frequency of the Neandertal-like tag-alleles selected for
the archaic loci. For each tissue we computed the number
of random non-archaic loci with a smaller GEA P value
than the empirical 5% quantile defined based on the
archaic loci P value distribution. At random, we would
expect that non-archaic alleles reach the 5% quantile
cutoff as often as the archaic alleles. In order to
compute statistical significance, we repeated the re-
sampling of non-archaic alleles 1000 times. The pro-
portion of samples with at least as many significant
GEAs gives us an empirical P value for each tissue.
To compute an empirical P value over all tissues, we
sum over all tissues for archaic loci and 1000 random
samples of non-archaic loci. We repeated these ana-
lyses for archaic loci with Neandertal allele frequencies
greater than and equal to 5%, and archaic loci with a
Neandertal allele frequency lower than 5%. We cor-
rected the obtained tissue-wise P values for multiple
testing using the Benjamini-Hochberg procedure [46];
the reported expression FDR values therefore account
for all tissue-specific tests performed.
Detecting non-synonymous Neandertal alleles and
computing deleteriousness
To identify synonymous and non-synonymous variants in
present-day non-African human populations (Europeans,
East Asians, and South Asians) [13] we used the variant
effect predictor software (vep [15]). We selected non-
synonymous variants (vep ID missense_variant) and syn-
onymous Neandertal-like alleles (vep ID synonymous_var-
iant) at a frequency greater than zero and used our defined
archaic allele set (“Methods”, paragraph 2) to define these
as introgressed alleles or non-introgressed alleles.
Comparing deleteriousness scores between
Neandertal-like alleles and non-archaic alleles
To classify non-synonymous changes according to their
potential impact on the protein we used two scores,
PolyPhen2 and SIFT [17, 18]. For each of the three
meta-populations, Europeans, East Asians, and South
Asians, we computed the average SIFT and PolyPhen2
deleteriousness scores for all non-synonymous variants
in each population. To compare deleteriousness scores
for the Neandertal non-synonymous variants to the
scores for non-archaic non-synonymous allele, we sam-
pled 1000 sets of non-archaic, non-synonymous alleles
that were frequency matched to the Neandertal non-
synonymous variants and computed their average SIFT
and PolyPhen2 deleteriousness scores. The distribution
of average deleteriousness scores for matched non-
synonymous variants is shown in Fig. 1.
Assigning selection scores for expression-associated loci
To link selection scores to GEA loci, we computed for
each tissue the archaic loci with the lowest 5% GEA P
values. We then intersected SNPs in each locus with SNPs
reported by Mathieson et al. [21] and assigned the lowest
selection score P value to each locus. Loci with no over-
lapping SNP in the selection set were excluded. For the
remaining archaic loci we generated 1000 frequency- and
size-matched sets each of (i) archaic loci with a selection
score and a GEA P value outside the lowest 5% of the
GEA P value distribution and (ii) non-archaic loci with a
selection score and with a GEA P value smaller than the
5% quantile GEA P value of the archaic loci GEA P value
distribution in the corresponding tissue. Empirical enrich-
ment P values were calculated as the proportion of
random sets with a number of loci with a selection score
P value <0.05 equal to or larger than the number of such
loci with significant archaic GEAs with significant
selection associations. We summed the number of loci
with selection score P values <0.05 across tissues to assess
significance over all tissues and corrected the resulting
tissue-wise P values for multiple testing by the Benjamini-
Hochberg procedure [46].
Allele frequency changes for loci with significant selection
scores
We compared the number of significant selection scores
for Neandertal non-synonymous variants to two back-
ground sets: (i) frequency-matched, non-synonymous non-
archaic alleles; and (ii) Neandertal synonymous variants.
For the first comparison we sampled 1000 sets of non--
archaic non-synonymous alleles that were frequency
matched to the Neandertal non-synonymous variants and
computed the number of significant selection scores and
the direction of the allele frequency change in each set.
Due to the lower number of synonymous variants with se-
lection scores, compared to non-synonymous Neandertal
variants with selection scores, we were not able to imple-
ment a re-sampling strategy. However, since the distribu-
tions on synonymous and non-synonymous archaic
variants do not differ (Mann-Whitney U test, P = 0.63), we
compared the number of significant selection scores and
the direction of their frequency changes directly in each
population using Fisher’s exact test.
We compared the number of significant selection scores
for Neandertal GEAs to two background sets: (i) frequency-
matched non-archaic loci with differential expression; and
(ii) frequency-matched archaic loci with no differential
expression.
For both comparisons we sampled 1000 sets of (i)
frequency-matched non-archaic loci with differential
expression and (ii) frequency-matched archaic loci with
no differential expression and computed the number of
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significant selection scores and the direction of the allele
frequency change in each set.
Overlap of archaic alleles associated with differential
expression with modern human phenotype data
We queried GWASdb [47, 49–72] to identify Neandertal-
like alleles present in the most significant GEA loci (top 1%
in a tissue; Additional file 1: Table S4) or the set of non-
synonymous Neandertal alleles (Additional file 1: Table S5).
We required that the association be either significant
genome-wide (GWAS P value <1 × 10−8) or the top candi-
date in the corresponding publication with a P value of 1 ×
10−5 or lower.
Confirming that the identified loci are of archaic origin
For each candidate non-synonymous archaic SNP we
extracted the Neandertal-like locus on which this SNP oc-
curs. For the selection candidates and the GEA candidates
we used the associated locus. We then defined the length
of the putative archaic haplotype for each locus as the
length of the segment between the two most distant ar-
chaic SNPs. To determine whether these putative archaic
haplotypes are longer than expected due to incomplete
lineage sorting, we used the approach by Huerta-Sánchez
et al. [3], applying the age of the Altai Neandertal based
on two commonly used mutation rates (μ = 1 × 10−8 and
0.5 × 10−8) [1] and the average recombination rates at each
locus [48] (Additional file 1: Tables S4 and S5).
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